GlassScriptPhysician profile
Lisa A Green
NPI 1558869529
$6,470.71
in general payments reported to CMS, 2019-2025
36 companies · $1,596 in 2025
The $1,596 reported for 2025 was more than what 91% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $881 · 2022: $1,125 · 2023: $1,100 · 2024: $1,768 · 2025: $1,596.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,453 · Education: $11.29.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,452.94 |
| Education | $11.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,409.02 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $707.37 | 2021-2025 | Mounjaro, Jardiance, Trulicity |
| Medtronic, INC. | $606.91 | 2021-2025 | Minimed 780g |
| Sanofi-Aventis U.S. LLC | $508.25 | 2021-2023 | |
| Corcept Therapeutics | $452.92 | 2023-2025 | Korlym |
| Novartis Pharmaceuticals Corporation | $346.32 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $305.92 | 2021-2025 | Farxiga, Lokelma |
| Amgen INC. | $219.93 | 2021-2025 | Evenity, Prolia, Prolia |
| Amphastar Pharmaceuticals, INC. | $214.22 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $209.91 | 2021-2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $199.66 | 2022-2025 | |
| Insulet Corporation | $155.28 | 2024-2025 | Omnipod |
| Dexcom, INC. | $135.38 | 2023-2025 | Dexcom G6 Transmitter |
| Xeris Pharmaceuticals, INC. | $119.58 | 2021-2025 | Gvoke Hypopen, Recorlev |
| Radius Health, INC. | $113.18 | 2021-2024 | Tymlos |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $92.89 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $83.66 | 2021-2023 | Steglatro, Steglujan, Januvia |
| Abbott Laboratories | $73.85 | 2022-2024 | Freestyle Libre 3 |
| Tandem Diabetes Care, INC. | $61.74 | 2024 | T:Slim X2 Insulin Pump With Control-Iq |
| Astellas Pharma US INC | $43.36 | 2024-2025 | Veozah |
| Recordati_rare_diseases_inc. | $40.10 | 2025 | Isturisa |
| Intuity Medical INC | $34.03 | 2023 | Pogo Automatic Blood Glucose Monitoring System |
| Ascensia Diabetes Care US INC. | $32.70 | 2024 | |
| Neurocrine Biosciences, INC. | $32.31 | 2024 | |
| Beta Bionics, INC. | $30.80 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Sanofi US Services INC. | $29.80 | 2025 | |
| Mannkind Corporation | $29.54 | 2025 | |
| Pfizer INC. | $26.73 | 2024 | |
| Averitas Pharma INC. | $26.36 | 2025 | Qutenza |
| Boston Scientific Corporation | $26.09 | 2024 | Lux-Dx Insertable Cardiac Monitor |
| Sequel Med Tech, LLC | $23.18 | 2025 | Twiist |
| Almatica Pharma LLC | $20.59 | 2024 | Loreev Xr |
| Ascendis Pharma Endocrinology INC | $15.74 | 2025 | Skytrofa |
| Cequr Corporation | $15.25 | 2024 | Cequr Simplicity |
| Janssen Biotech, INC. | $14.14 | 2021 | |
| Cvrx, INC. | $14.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Green listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.